Increased levels of your insulin-like growth factor-1 (IGF-1). Stop using EGRIFTA SV ® if any cancer symptoms come back. Increased risk of new cancer in HIV positive patients or your cancer coming back (reactivation). Have problems with blood sugar or diabetes.Īre taking any other prescription and non-prescription medicines, vitamins, and herbal supplements.ĮGRIFTA SV ® may cause serious side effects including: If you become pregnant, stop using EGRIFTA SV ® and talk with your healthcare provider.īefore using EGRIFTA SV ®, tell your healthcare provider if you: Have a pituitary gland tumor, surgery, or other problems related to your pituitary gland, or have had radiation treatment to your head or head injury.Īre allergic to tesamorelin or any of the ingredients in EGRIFTA SV ®.Īre pregnant or become pregnant. It is not known if EGRIFTA SV ® is safe and effective in children, do not use in children. It is not known whether taking EGRIFTA SV ® helps improve how well you take your antiretroviral medications. The long-term safety of EGRIFTA SV ® on the heart and blood vessels (cardiovascular) is not known. EGRIFTA SV ® is a growth hormone-releasing factor (GHRF) analog.ĮGRIFTA SV ® is not for weight loss management. What is EGRIFTA SV ® (tesamorelin for injection)?ĮGRIFTA SV ® is an injectable prescription medicine used to reduce excess abdominal fat in adult patients living with HIV and lipodystrophy.
0 kommentar(er)
